Centile Bioscience
PrivateLast Round
Seed Round
Apr 16, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Centile Bioscience is a healthcare technology company that enables data-driven diagnosis, patient insights, and therapeutic development for brain diseases and disorders by transforming MRI and CT scans into quantitative biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centile Bioscience Comparables
Compare Centile Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qynapse | 86% | |
| Brainreader | 84% | |
| Quibim | 83% |
Centile Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 16, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
$3M seed round completed.
Centile Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Centile Bioscience's valuation, stock price, and market status.
Is Centile Bioscience a public or private company?
Centile Bioscience is a private company.
What is the current stock price of Centile Bioscience?
Centile Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Centile Bioscience worth (valuation)?
Valuation information for Centile Bioscience is not publicly available.
Can I buy Centile Bioscience stock?
Centile Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Centile Bioscience's last funding round?
Centile Bioscience's most recent funding round was Seed Round on April 16, 2026.
Who are the main investors in Centile Bioscience?
Investor information for Centile Bioscience is not publicly disclosed.
Will Centile Bioscience IPO soon?
No public IPO plans have been announced for Centile Bioscience.
How can I track Centile Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Centile Bioscience's secondary market activity and sign up for updates.